Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT06751459
Eligibility Criteria:
Inclusion Criteria:
* 1\. Adults aged 19 years or older who have voluntarily provided written informed consent to participate in this clinical trial.
2\. Individuals who have been diagnosed with atrial fibrillation prior to the date of informed consent acquisition.
3\. Individuals who are scheduled to undergo catheter ablation for atrial fibrillation within three months from the date of informed consent acquisition.
Exclusion Criteria:
* 1\. Individuals with a history of catheter ablation prior to obtaining informed consent.
2\. Individuals with sensitive skin, allergic skin conditions, skin cancer, rashes, or other dermatological disorders.
3\. Individuals with implanted cardiac devices, such as pacemakers, implantable defibrillators, or other implantable electronic devices.
4\. Individuals deemed by the investigator to be at an increased risk or otherwise unsuitable for participation in the clinical trial.
5\. Individuals with cognitive impairments that make it difficult to understand trial information or voluntarily make an informed decision.
6\. Pregnant or breastfeeding women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06751459
Study Brief:
Protocol Section:
NCT06751459